Scientific Director, Chemical & Process Development at Bristol-Myers Squibb

New Brunswick, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Ph.D. in Chemistry or M.Sc. with 15 years experience in chemical/process development
Strong background in chemical development; experience with ADCs and TIDES preferred
Proven ability to lead cross-functional teams and global collaborations
Experience in outsourcing strategies and external partnerships
Actively contributes to the scientific community through high-quality publications in peer-reviewed journals

Responsibilities

Leverage a deep understanding and application of process chemistry principles, including route assessment, invention, and optimization to drive project strategy
Lead activities related to chemical and process development for various modalities; identify trends and apply new solutions
Experience representing leading Drug Substance strategies in cross-functional CMC teams and broader enterprise
Ensure external partners deliver measurable value and support long-term business objectives
Effectively manage external FTEs and partners, maintaining accountability for performance, timelines, and deliverables
Collaborate to shape departmental strategy, influence technology decisions, and manage resources and budgets for critical projects
Champions innovation by leveraging digital and automation tools to improve processes
Proactively establish KPIs to measure performance and inform continuous improvement and investment opportunities
Develop talent at different career stages through coaching, mentoring and guiding principles
Strengthen the depth and breadth of project leaders within Chemical & Process Development, promoting a “One CPD” mindset

Skills

Organic Chemistry

Analytical Chemistry

Chemical Engineering

Process Development

Synthesis

Data-driven decision-making

Teamwork

Resource Allocation

Budget Allocation

Operational Leadership

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free